BIBLIO is the largest independent book marketplace in the world, with over 100 million books.

Skip to content

Valuation in Life Sciences: A Practical Guide

Valuation in Life Sciences: A Practical Guide

Valuation in Life Sciences: A Practical Guide
Stock photo: cover may vary

Valuation in Life Sciences: A Practical Guide Hardback - 0000 - 1st Edition

by Boris Bogdan; Ralph Villiger

Add to wish list
  • Used
  • Hardback
  • first
Used: Good

Description

Springer, 0000-00-00. 1. hardcover. Used: Good. 6.10x0.63x9.25. Buy with confidence. Excellent Customer Service & Return policy.
Ask the seller a question Add to wish list
A$55.66
Free Delivery within USA
Standard delivery: 5 to 10 days
More delivery options
Dropship order
Ships from Ergodebooks (Texas, United States)
The BIBLIO Guarantee

Details

  • Title Valuation in Life Sciences: A Practical Guide
  • Author Boris Bogdan; Ralph Villiger
  • Binding Hardback
  • Edition number 1st
  • Edition 1
  • Condition Used: Good
  • Pages 249
  • Volumes 1
  • Language ENG
  • Publisher Springer
  • Publication date 0000-00-00
  • Bookseller's Inventory # SONG3540455655
  • ISBN 9783540455653 / 3540455655
  • Weight 1.2 lbs (0.54 kg)
  • Dimensions 9.21 x 6.14 x 0.63 in (23.39 x 15.60 x 1.60 cm)
  • Size 6.10x0.63x9.25
  • Category Business / Economics / Finance
  • Library of Congress Catalogue Number 2006938913
  • Dewey Decimal Code 610.6
  • Quantity available 1

About Ergodebooks Texas, United States

Specialising in: Rare Books, Rare Dvd, Rare Video, Textbook
Biblio member since 2005

Our goal is to provide best customer service and good condition books for the lowest possible price. We are always honest about condition of book. We list book only by ISBN # and hence exact book is guaranteed.

Terms of Sale:

We have 30 day return policy.

Browse books from Ergodebooks

Reader reviews for Valuation in Life Sciences: A Practical Guide

Write a review for this book

There are no reviews for this book yet. Be the first to write a review!

Your review will be anonymous unless you login or create an account first.

Overall rating
Remember: You’re rating the book as a work, not the seller or the condition of the specific copy you purchased!

Important Terms and Guidelines

  • Please focus on the book’s content and context. Also, add any personal comments as to how you enjoyed the book. Substantiate your likes and dislikes. You may make comparisons to other books.
  • Reviews must be at least 140 characters in length.
  • Please do not reveal critical plot elements.
  • This is not a help line. Contact customer support if you need help.
Your review must not include:
  • Obscenities, discriminatory language, or other insulting language not suitable for public domain
  • Advertisements, “spam” content, or references to other products, offers or websites.
  • Email addresses, URLs, phone numbers, physical addresses or other contact information.
  • Overly critical comments about other reviews or reviewers
  • Time-sensitive material (i.e. promotional tours, seminars, lectures, etc.)
  • Availability, price, or alternative ordering/shipping information

From the publisher

This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including discounted cash-flow and real options, the authors demonstrate how to value projects, patents, licences, firms and stocks on real-life examples, even treating complex licence and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results. Ralph Villiger and Boris Bogdan have written what is sure to become the industry standard reference for valuation of pharmaceutical and biotechnology projects and companies. At a time when the healthcare industry is placing increasing emphasis on licensing and M&A as a core strategy this book provides a firm understanding of the way in which products and businesses can be valued at all stages of their development.

Dr. Martin Buckland, Chief Business Officer, Astex Therapeutics, Cambridge, UK

The book presents a number of innovative ideas, illustrated with practical examples that should improve decision-making in the drug development process, intellectual property evaluation, licensing and sublicensing. The authors make a persuasive case for the use of advanced techniques and the section on worked-examples should be particularly appealing to practitioners.

Dr. Martin Grossmann, Novartis Pharmaceuticals

There is no doubt that this book will become an essentialreference tool for professionals in technology transfer, business developers and biotech companies, as well as the pharmaceutical industry and Life Science investors.

Jean-Pierre Saintouil, Director of Technology Transfer Department, Institut Pasteur, Paris, France

Please wait a moment while we load the requested page.

tracking-